share_log

Alliance Global Partners Maintains Neutral on T2 Biosystems, Lowers Price Target to $1.5

Alliance Global Partners Maintains Neutral on T2 Biosystems, Lowers Price Target to $1.5

Aliance Global Partners对T2生物系统保持中立,将目标价下调至1.5美元
Benzinga Real-time News ·  2023/01/24 08:08

Alliance Global Partners analyst Ben Haynor maintains T2 Biosystems (NASDAQ:TTOO) with a Neutral and lowers the price target from $2.2 to $1.5.

Alliance Global Partners分析师本·海诺将T2 Biosystems(纳斯达克股票代码:TTOO)维持在中性,并将目标股价从2.2美元下调至1.5美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发